Dr. Erin T. Bird, MD

Dr. Bird practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Bird's NPI, 1932169190, was assigned on March 23, 2006. Dr. Bird graduated from Baylor College Of Medicine in 1993. Dr. Bird holds Texas license J7307.

Dr. Bird's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Bird's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Bird is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Bird to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bird practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bird's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bird is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dr. Bird is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney stone disease, testicular dysfunction, urinary endoscopy and UTI among the conditions Dr. Bird treats.

CMS data shows 182 Medicare services from Dr. Bird across 7 procedure codes in 2024, for 173 Medicare patients. Medicare paid $10,904 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Bird in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bird's median patient age at 66, with 44% women.

In 2024, Dr. Bird wrote 48 Medicare Part D claims for 29 patients. 77% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $5,897 in total drug cost. In 2023, CMS named 53 claims across 4 drugs.

Dr. Bird accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 55 papers to Dr. Bird, published from 2003 to 2023. 2016 was the busiest year, with 5. The most frequent topics are Urinary Bladder, Overactive, Electric Stimulation Therapy and Lumbosacral Plexus. Dr. Bird has published most often in Urology. Dr. Bird's most frequent co-authors are Jill McHenry Danford, MD, Marawan El Tayeb, MD and Rachel Alice High, DO.

Dmand AI links Dr. Bird to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Nocturnal Enuresis, Urinary Incontinence, Stress and Enuresis.

CMS Open Payments shows 46 general payments to Dr. Bird from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $1,503.

Dr. Bird graduated from Baylor College Of Medicine in 1993.

Dr. Bird is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.